Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CRISPR01:59

CRISPR

49.1K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
49.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of dosimetric consistency between pre- and postoperative CT-guided noncoplanar template-assisted ¹²⁵I seed implantation in recurrent and metastatic thoracic tumors: a retrospective study.

PeerJ·2026
Same author

Local efficacy and safety of CT-guided Iodine-125 seed implantation in the treatment of recurrent malignant tumors: a retrospective study.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2025
Same author

Dosimetry study of 3D-printed noncoplanar template-assisted CT-guided 125I seed implantation for the treatment of recurrent and metastatic tumors in the head and neck.

PloS one·2025
Same author

FK506-binding proteins: Emerging target and therapeutic opportunity in multiple tumors.

International journal of biological macromolecules·2025
Same author

Integrated analysis of FKBP1A/SLC3A2 axis in everolimus inducing ferroptosis of breast cancer and anti-proliferation of T lymphocyte.

International journal of medical sciences·2023
Same author

Retraction Notice to: Comprehensive analysis of FKBP4/NR3C1/TMEM173 signaling pathway in triple-negative breast cancer cell and dendritic cell among tumor microenvironment.

Molecular therapy oncolytics·2022
Same journal

Neonatal expression of human FMRP isoform corrects cortical deficits and improves behavior in a mouse model of fragile X syndrome.

Molecular therapy. Nucleic acids·2026
Same journal

Meta-analysis of adverse events in clinical studies with antisense oligonucleotide therapies.

Molecular therapy. Nucleic acids·2026
Same journal

A versatile VLP-mediated CRISPR-RNP platform for precise genome editing and durable epigenome silencing in cancer.

Molecular therapy. Nucleic acids·2026
Same journal

Pyroptosis as a novel therapeutic target in glioblastoma multiforme: Mechanisms, molecular insights, and therapeutic potential.

Molecular therapy. Nucleic acids·2026
Same journal

Selection and validation of novel DNA aptamer panel co-specific to <i>Plasmodium falciparum</i> and <i>Plasmodium ovale</i> lactate dehydrogenase.

Molecular therapy. Nucleic acids·2026
Same journal

Therapeutic rescue of pathogenic asparaginyl-tRNA synthetase alleles.

Molecular therapy. Nucleic acids·2026
See all related articles

Related Experiment Video

Updated: May 29, 2025

Author Spotlight: Simplifying Genome-Wide Plasmid Library Construction Using CRISPRmass
05:30

Author Spotlight: Simplifying Genome-Wide Plasmid Library Construction Using CRISPRmass

Published on: May 17, 2024

841

High-accuracy crRNA array assembly strategy for multiplex CRISPR.

Xiangtong Zhao1,2, Lixian Yang3, Peng Li4

  • 1Henan Provincial Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou, Henan, China.

Molecular Therapy. Nucleic Acids
|February 3, 2025
PubMed
Summary
This summary is machine-generated.

This study introduces a novel, efficient strategy for assembling CRISPR arrays, enabling simultaneous targeting of multiple genes. This advancement facilitates complex cellular network analysis and holds promise for multi-target gene therapies.

Keywords:
AsCas12aCRISPR arrayGolden Gate AssemblyMT: RNA/DNA EditingPol II promoterPol III promoterRfxCas13dcrRNAmultiplex CRISPR

More Related Videos

Dissection of Enhancer Function Using Multiplex CRISPR-based Enhancer Interference in Cell Lines
10:46

Dissection of Enhancer Function Using Multiplex CRISPR-based Enhancer Interference in Cell Lines

Published on: June 2, 2018

9.2K
CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
10:40

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

2.3K

Related Experiment Videos

Last Updated: May 29, 2025

Author Spotlight: Simplifying Genome-Wide Plasmid Library Construction Using CRISPRmass
05:30

Author Spotlight: Simplifying Genome-Wide Plasmid Library Construction Using CRISPRmass

Published on: May 17, 2024

841
Dissection of Enhancer Function Using Multiplex CRISPR-based Enhancer Interference in Cell Lines
10:46

Dissection of Enhancer Function Using Multiplex CRISPR-based Enhancer Interference in Cell Lines

Published on: June 2, 2018

9.2K
CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
10:40

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

2.3K

Area of Science:

  • Molecular Biology
  • Gene Editing Technologies
  • Systems Biology

Background:

  • Multiplex CRISPR enables simultaneous targeting of multiple genetic loci for complex cellular network analysis.
  • Existing CRISPR array assembly methods lack convenience, accuracy, and efficiency.
  • Emerging Cas nucleases and CRISPR arrays have expanded multiplex CRISPR applications in vitro and in vivo.

Purpose of the Study:

  • To develop a streamlined, accurate, cost- and time-saving strategy for CRISPR array assembly.
  • To facilitate the convenient implementation of multiplex CRISPR for DNA and RNA targets.
  • To enable dissection of complex cellular networks and advance multi-target gene therapy.

Main Methods:

  • Developed a novel strategy for CRISPR array assembly.
  • Efficiently assembled 12 CRISPR RNAs (crRNAs) for AsCas12a and 15 crRNAs for RfxCas13d in a single reaction.
  • Investigated CRISPR array expression patterns driven by Pol II versus Pol III promoters and developed improved methods for long CRISPR array expression.

Main Results:

  • Demonstrated a highly accurate, cost- and time-saving CRISPR array assembly strategy.
  • Successfully assembled large numbers of crRNAs in a single reaction for both DNA (AsCas12a) and RNA (RfxCas13d) targeting.
  • Observed distinct expression patterns for CRISPR arrays driven by Pol II and Pol III promoters, allowing for controlled CRISPR intensity distribution.

Conclusions:

  • The novel strategy provides a flexible and powerful tool for multiplex CRISPR implementation.
  • This approach significantly facilitates the dissection of complex biological networks.
  • The developed method is crucial for advancing multi-target gene therapy and understanding cellular functions.